Cargando…
Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility
BACKGROUND: TEX101 is a cell membrane protein exclusively expressed by testicular germ cells and shed into seminal plasma. We previously verified human TEX101 as a biomarker for the differential diagnosis of azoospermia, and developed a first-of-its-kind TEX101 ELISA. To demonstrate the clinical uti...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363040/ https://www.ncbi.nlm.nih.gov/pubmed/28330469 http://dx.doi.org/10.1186/s12916-017-0817-5 |
_version_ | 1782517095192330240 |
---|---|
author | Korbakis, Dimitrios Schiza, Christina Brinc, Davor Soosaipillai, Antoninus Karakosta, Theano D. Légaré, Christine Sullivan, Robert Mullen, Brendan Jarvi, Keith Diamandis, Eleftherios P. Drabovich, Andrei P. |
author_facet | Korbakis, Dimitrios Schiza, Christina Brinc, Davor Soosaipillai, Antoninus Karakosta, Theano D. Légaré, Christine Sullivan, Robert Mullen, Brendan Jarvi, Keith Diamandis, Eleftherios P. Drabovich, Andrei P. |
author_sort | Korbakis, Dimitrios |
collection | PubMed |
description | BACKGROUND: TEX101 is a cell membrane protein exclusively expressed by testicular germ cells and shed into seminal plasma. We previously verified human TEX101 as a biomarker for the differential diagnosis of azoospermia, and developed a first-of-its-kind TEX101 ELISA. To demonstrate the clinical utility of TEX101, in this work we aimed at evaluating ELISA performance in a large population of fertile, subfertile, and infertile men. METHODS: Mass spectrometry, size-exclusion chromatography, ultracentrifugation, and immunohistochemistry were used to characterize TEX101 protein as an analyte in seminal plasma. Using the optimized protocol for seminal plasma pretreatment, TEX101 was measured by ELISA in 805 seminal plasma samples. RESULTS: We demonstrated that TEX101 was present in seminal plasma mostly in a free soluble form and that its small fraction was associated with seminal microvesicles. TEX101 median values were estimated in healthy, fertile pre-vasectomy men (5436 ng/mL, N = 64) and in patients with unexplained infertility (4967 ng/mL, N = 277), oligospermia (450 ng/mL, N = 270), and azoospermia (0.5 ng/mL, N = 137). Fertile post-vasectomy men (N = 57) and patients with Sertoli cell-only syndrome (N = 13) and obstructive azoospermia (N = 36) had undetectable levels of TEX101 (≤0.5 ng/mL). A cut-off value of 0.9 ng/mL provided 100% sensitivity at 100% specificity for distinguishing pre- and post-vasectomy men. The combination of a concentration of TEX101 > 0.9 ng/mL and epididymis-specific protein ECM1 > 2.3 μg/mL provided 81% sensitivity at 100% specificity for differentiating between non-obstructive and obstructive azoospermia, thus eliminating the majority of diagnostic testicular biopsies. In addition, a cut-off value of ≥0.6 ng/mL provided 73% sensitivity at 64% specificity for predicting sperm or spermatid retrieval in patients with non-obstructive azoospermia. CONCLUSIONS: We demonstrated the clinical utility of TEX101 ELISA as a test to evaluate vasectomy success, to stratify azoospermia forms, and to better select patients for sperm retrieval. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-017-0817-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5363040 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53630402017-03-24 Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility Korbakis, Dimitrios Schiza, Christina Brinc, Davor Soosaipillai, Antoninus Karakosta, Theano D. Légaré, Christine Sullivan, Robert Mullen, Brendan Jarvi, Keith Diamandis, Eleftherios P. Drabovich, Andrei P. BMC Med Research Article BACKGROUND: TEX101 is a cell membrane protein exclusively expressed by testicular germ cells and shed into seminal plasma. We previously verified human TEX101 as a biomarker for the differential diagnosis of azoospermia, and developed a first-of-its-kind TEX101 ELISA. To demonstrate the clinical utility of TEX101, in this work we aimed at evaluating ELISA performance in a large population of fertile, subfertile, and infertile men. METHODS: Mass spectrometry, size-exclusion chromatography, ultracentrifugation, and immunohistochemistry were used to characterize TEX101 protein as an analyte in seminal plasma. Using the optimized protocol for seminal plasma pretreatment, TEX101 was measured by ELISA in 805 seminal plasma samples. RESULTS: We demonstrated that TEX101 was present in seminal plasma mostly in a free soluble form and that its small fraction was associated with seminal microvesicles. TEX101 median values were estimated in healthy, fertile pre-vasectomy men (5436 ng/mL, N = 64) and in patients with unexplained infertility (4967 ng/mL, N = 277), oligospermia (450 ng/mL, N = 270), and azoospermia (0.5 ng/mL, N = 137). Fertile post-vasectomy men (N = 57) and patients with Sertoli cell-only syndrome (N = 13) and obstructive azoospermia (N = 36) had undetectable levels of TEX101 (≤0.5 ng/mL). A cut-off value of 0.9 ng/mL provided 100% sensitivity at 100% specificity for distinguishing pre- and post-vasectomy men. The combination of a concentration of TEX101 > 0.9 ng/mL and epididymis-specific protein ECM1 > 2.3 μg/mL provided 81% sensitivity at 100% specificity for differentiating between non-obstructive and obstructive azoospermia, thus eliminating the majority of diagnostic testicular biopsies. In addition, a cut-off value of ≥0.6 ng/mL provided 73% sensitivity at 64% specificity for predicting sperm or spermatid retrieval in patients with non-obstructive azoospermia. CONCLUSIONS: We demonstrated the clinical utility of TEX101 ELISA as a test to evaluate vasectomy success, to stratify azoospermia forms, and to better select patients for sperm retrieval. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-017-0817-5) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-23 /pmc/articles/PMC5363040/ /pubmed/28330469 http://dx.doi.org/10.1186/s12916-017-0817-5 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Korbakis, Dimitrios Schiza, Christina Brinc, Davor Soosaipillai, Antoninus Karakosta, Theano D. Légaré, Christine Sullivan, Robert Mullen, Brendan Jarvi, Keith Diamandis, Eleftherios P. Drabovich, Andrei P. Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility |
title | Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility |
title_full | Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility |
title_fullStr | Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility |
title_full_unstemmed | Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility |
title_short | Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility |
title_sort | preclinical evaluation of a tex101 protein elisa test for the differential diagnosis of male infertility |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363040/ https://www.ncbi.nlm.nih.gov/pubmed/28330469 http://dx.doi.org/10.1186/s12916-017-0817-5 |
work_keys_str_mv | AT korbakisdimitrios preclinicalevaluationofatex101proteinelisatestforthedifferentialdiagnosisofmaleinfertility AT schizachristina preclinicalevaluationofatex101proteinelisatestforthedifferentialdiagnosisofmaleinfertility AT brincdavor preclinicalevaluationofatex101proteinelisatestforthedifferentialdiagnosisofmaleinfertility AT soosaipillaiantoninus preclinicalevaluationofatex101proteinelisatestforthedifferentialdiagnosisofmaleinfertility AT karakostatheanod preclinicalevaluationofatex101proteinelisatestforthedifferentialdiagnosisofmaleinfertility AT legarechristine preclinicalevaluationofatex101proteinelisatestforthedifferentialdiagnosisofmaleinfertility AT sullivanrobert preclinicalevaluationofatex101proteinelisatestforthedifferentialdiagnosisofmaleinfertility AT mullenbrendan preclinicalevaluationofatex101proteinelisatestforthedifferentialdiagnosisofmaleinfertility AT jarvikeith preclinicalevaluationofatex101proteinelisatestforthedifferentialdiagnosisofmaleinfertility AT diamandiseleftheriosp preclinicalevaluationofatex101proteinelisatestforthedifferentialdiagnosisofmaleinfertility AT drabovichandreip preclinicalevaluationofatex101proteinelisatestforthedifferentialdiagnosisofmaleinfertility |